Maternal Risk Screening for Preeclampsia

Connected devices, AI screening and ultrasound of uterine and ophthalmic arteries for early detection of preeclampsia in primary care.

tabular visionunverified

0named models

692candidates

1deployments

1in Indonesia

Named Models

The research names no model for this use case.

Where this comes from

Models the research names for this use case. Research, with sources on each model record.

Who Runs It

pilot, 1

Kemenkes with Queenrides, PT Tele Cexup Indonesia and Indonesia Prenatal Institute (puskesmas in DKI Jakarta and Garut)Country: IndonesiaIoMT and AI preeclampsia screening with ultrasound of uterine and ophthalmic arteries (model not named)Vendor: Queenrides; PT Tele Cexup Indonesia; Indonesia Prenatal InstitutepilotDate21 Apr 2026Early results: detection rate up to 50 percent higherEvidence: government statementConfidence: mediumSource: kemkes.go.id, medcom.id, en.wikipedia.org

Where this comes from

Documented uses by named organisations. The evidence column says who made the claim.

Candidate Models

COCO val

A general benchmark for this model class, not a test on this use case. Object detection and segmentation AP (mAP50-95). Higher is better. Showing 10 of 11.

RF-DETR 2XLRoboflow vendor-reported60.1

YOLO26xUltralytics vendor-reported57.5

YOLO26lUltralytics vendor-reported55

D-FINEUniversity of Science and Technology of China (USTC), Institute of Artificial Intelligence, Hefei Comprehensive National Science Center independent55

RF-DETR MRoboflow vendor-reported54.7

YOLO26mUltralytics vendor-reported53.1

RF-DETR SRoboflow vendor-reported52.9

YOLO26sUltralytics vendor-reported48.6

YOLO11Ultralytics independent48.3

RF-DETR NRoboflow vendor-reported48

050100

YOLO26lUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 months

YOLO26mUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 months

YOLO26nUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 months

YOLO26sUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 months

XGBoostDMLC community, tabularReleasedAug 2026open weightshas scoreslast 18 months

LightGBMMicrosoft AI, tabularReleasedJul 2026open weightshas scoreslast 18 months

TabPFN-2.6Prior Labs, tabularReleasedMar 2026open weightshas scoreslast 18 months

CatBoostYandex, tabularReleasedFeb 2026open weightshas scoreslast 18 months

YOLO26xUltralytics, visionReleasedJan 2026open weightshas scoreslast 18 months

AutoGluon 1.5Amazon, tabularReleased2026open weightshas scoreslast 18 months

Showing 10 of 692. All models of this class

Where this comes from

Derived, not researched: models in the directory whose class matches a class this use case uses, excluding family records and models shut down or deprecated. Ranked by how many fit facts they meet, then by release date. Each fit fact is read from the model record.

Use Case

Industry: healthcare and pharma
Model classes: tabularvisionunverified
Benchmarks or datasets: not in the notes
Regulatory notes: Surat Edaran Menkominfo 9/2023 Etika Kecerdasan Artifisial, Kementerian Komunikasi dan Informatika (now Kementerian Komunikasi dan Digital)Maternal risk screening for preeclampsia is an AI-based service run by an electronic system operator, and the circular asks such operators to build and use AI on the values of inclusivity, transparency, humanity and security.
UU 27/2022 Pelindungan Data Pribadi, DPR and President of the Republic of Indonesia (administered by Kementerian Komunikasi dan Digital)Maternal risk screening for preeclampsia processes health data of patients, which the law treats as a specific category of personal data, so the controller needs a lawful basis, must protect the data and must honour data subject rights.
UU 17/2023 Kesehatan, DPR and President of the Republic of Indonesia (administered by Kementerian Kesehatan)Maternal risk screening for preeclampsia is used in delivering health services or handling patient records, which this law governs through rules on medical records, health information systems, health technology and medical devices.
EU AI Act, Regulation (EU) 2024/1689 (international), European UnionMaternal risk screening for preeclampsia is software that may qualify as a medical device or a safety component of one; the EU AI Act treats such AI as high-risk when the product is placed on the EU market.

Where this comes from

From the industry tracks T08 to T10 of the research notes.

R&D Topics

Links to R&D topics are awaiting review.

Where this comes from

Which R&D topics would most change this use case. Drafted by Claude from the topic definitions and the use case; proposed until approved.

Opportunities

Opportunities are awaiting review.

Where this comes from

Gaps found by rule in what the directory holds for this use case. Each is a proposal for review.

Links

IndustryHealthcare40 use cases, 66 deployments

Use CaseMaternal Risk Screening for PreeclampsiaHealthcare

Modelsnone recorded

Who Runs It

Kemenkes with Queenrides, PT Tele Cexup Indonesia and Indonesia Prenatal Institute (puskesmas in DKI Jakarta and Garut)Pilot, 21 Apr 2026

Graph

Deployments 1

Kemenkes with Queenrides, PT Tele Cexup Indonesia and Indonesia Prenatal Institute (puskesmas in DKI Jakarta and Garut)IoMT and AI preeclampsia screening with ultrasound of uterine and ophthalmic arteries (model not named), Indonesia

Sources

kemkes.go.id/id/peringati-hari-kartini-kemenkes-perkuat-de... https://kemkes.go.id/id/peringati-hari-kartini-kemenkes-perkuat-deteksi-dini-preeklamsia-berbasis-teknologi

To cite this page: Project AURION, AI Use-Cases Research & Innovation, "Maternal Risk Screening for Preeclampsia", https://aurion.semai.id/usecases/hc-maternal-risk-screening/, records of October 2026.